Advancells BMC Technologies is the leader in developing point-of-care platforms to concentrate autologous stem cells, growth factors, and accessory cells to help optimize the conditions for healing. The Advancells BMC concentrate system can be used with any recommended centrifugation system thereby eliminating the need for autograft by efficiently concentrating and recovering regenerative cells while retaining their cellular viability and proliferative potential. Advancells BMC system is the current gold standard in making use of Autologous bioactive cells derived from peripheral blood in hospital and office settings.